261 related articles for article (PubMed ID: 23625747)
1. Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group.
Warren KE; Poussaint TY; Vezina G; Hargrave D; Packer RJ; Goldman S; Wen PY; Pollack IF; Zurakowski D; Kun LE; Prados MD; Rutkowski S; Kieran MW
Pediatr Blood Cancer; 2013 Sep; 60(9):1397-401. PubMed ID: 23625747
[TBL] [Abstract][Full Text] [Related]
2. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Erker C; Tamrazi B; Poussaint TY; Mueller S; Mata-Mbemba D; Franceschi E; Brandes AA; Rao A; Haworth KB; Wen PY; Goldman S; Vezina G; MacDonald TJ; Dunkel IJ; Morgan PS; Jaspan T; Prados MD; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e317-e329. PubMed ID: 32502458
[TBL] [Abstract][Full Text] [Related]
3. Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lindsay HB; Massimino M; Avula S; Stivaros S; Grundy R; Metrock K; Bhatia A; Fernández-Teijeiro A; Chiapparini L; Bennett J; Wright K; Hoffman LM; Smith A; Pajtler KW; Poussaint TY; Warren KE; Foreman NK; Mirsky DM
Lancet Oncol; 2022 Aug; 23(8):e393-e401. PubMed ID: 35901835
[TBL] [Abstract][Full Text] [Related]
4. Evolution and implementation of radiographic response criteria in neuro-oncology.
Ramakrishnan D; von Reppert M; Krycia M; Sala M; Mueller S; Aneja S; Nabavizadeh A; Galldiks N; Lohmann P; Raji C; Ikuta I; Memon F; Weinberg BD; Aboian MS
Neurooncol Adv; 2023; 5(1):vdad118. PubMed ID: 37860269
[TBL] [Abstract][Full Text] [Related]
5. Response Assessment in Neuro-Oncology Clinical Trials.
Wen PY; Chang SM; Van den Bent MJ; Vogelbaum MA; Macdonald DR; Lee EQ
J Clin Oncol; 2017 Jul; 35(21):2439-2449. PubMed ID: 28640707
[TBL] [Abstract][Full Text] [Related]
6. Review of imaging recommendations from Response Assessment in Pediatric Neuro-Oncology (RAPNO).
Bhatia A; Sabin ND; Fisher MJ; Poussaint TY
Pediatr Radiol; 2023 Dec; 53(13):2723-2741. PubMed ID: 37864711
[TBL] [Abstract][Full Text] [Related]
7. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Fangusaro J; Witt O; Hernáiz Driever P; Bag AK; de Blank P; Kadom N; Kilburn L; Lober RM; Robison NJ; Fisher MJ; Packer RJ; Young Poussaint T; Papusha L; Avula S; Brandes AA; Bouffet E; Bowers D; Artemov A; Chintagumpala M; Zurakowski D; van den Bent M; Bison B; Yeom KW; Taal W; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e305-e316. PubMed ID: 32502457
[TBL] [Abstract][Full Text] [Related]
8. Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group.
Hoffman LM; Jaimes C; Mankad K; Mirsky DM; Tamrazi B; Tinkle CL; Kline C; Ramasubramanian A; Malbari F; Mangum R; Lindsay H; Horne V; Daniels DJ; Keole S; Grosshans DR; Young Poussaint T; Packer R; Cavalheiro S; Bison B; Hankinson TC; Müller HL; Bartels U; Warren KE; Chintagumpala M
Neuro Oncol; 2023 Feb; 25(2):224-233. PubMed ID: 36124689
[TBL] [Abstract][Full Text] [Related]
9. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
[TBL] [Abstract][Full Text] [Related]
10. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.
Jaspan T; Morgan PS; Warmuth-Metz M; Sanchez Aliaga E; Warren D; Calmon R; Grill J; Hargrave D; Garcia J; Zahlmann G
AJNR Am J Neuroradiol; 2016 Sep; 37(9):1581-7. PubMed ID: 27127006
[TBL] [Abstract][Full Text] [Related]
11. RAPNO efforts in Brain Tumour Outcomes.
Virani QU; Javed Z; Shamim MS
J Pak Med Assoc; 2024 May; 74(5):1005-1006. PubMed ID: 38783459
[TBL] [Abstract][Full Text] [Related]
12. Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Cooney TM; Cohen KJ; Guimaraes CV; Dhall G; Leach J; Massimino M; Erbetta A; Chiapparini L; Malbari F; Kramer K; Pollack IF; Baxter P; Laughlin S; Patay Z; Young Poussaint T; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e330-e336. PubMed ID: 32502459
[TBL] [Abstract][Full Text] [Related]
13. Response Assessment in Neuro-Oncology Criteria and Clinical Endpoints.
Huang RY; Wen PY
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):705-718. PubMed ID: 27742111
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.
Camidge DR; Lee EQ; Lin NU; Margolin K; Ahluwalia MS; Bendszus M; Chang SM; Dancey J; de Vries EGE; Harris GJ; Hodi FS; Lassman AB; Macdonald DR; Peereboom DM; Schiff D; Soffietti R; van den Bent MJ; Wefel JS; Wen PY
Lancet Oncol; 2018 Jan; 19(1):e20-e32. PubMed ID: 29304358
[TBL] [Abstract][Full Text] [Related]
15. Imaging Criteria in Neuro-oncology.
Nowosielski M; Wen PY
Semin Neurol; 2018 Feb; 38(1):24-31. PubMed ID: 29548049
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data.
Peng J; Zhou H; Tang O; Chang K; Wang P; Zeng X; Shen Q; Wu J; Xiao Y; Patel SH; Hu C; Jin K; Xiao B; Boxerman J; Gao X; Wen PY; Bai HX; Huang RY; Yang L
Neuro Oncol; 2020 Oct; 22(10):1536-1544. PubMed ID: 32215549
[TBL] [Abstract][Full Text] [Related]
17. Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.
Vogelbaum MA; Jost S; Aghi MK; Heimberger AB; Sampson JH; Wen PY; Macdonald DR; Van den Bent MJ; Chang SM
Neurosurgery; 2012 Jan; 70(1):234-43; discussion 243-4. PubMed ID: 21593697
[TBL] [Abstract][Full Text] [Related]
18. Response Assessment in Neuro-Oncology (RANO): more than imaging criteria for malignant glioma.
Chang SM; Wen PY; Vogelbaum MA; Macdonald DR; van den Bent MJ
Neurooncol Pract; 2015 Dec; 2(4):205-209. PubMed ID: 31386074
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group.
Arvold ND; Armstrong TS; Warren KE; Chang SM; DeAngelis LM; Blakeley J; Chamberlain MC; Dunbar E; Loong HH; Macdonald DR; Reardon DA; Vogelbaum MA; Yuan Y; Weller M; van den Bent M; Wen PY
Neuro Oncol; 2018 Jun; 20(7):897-906. PubMed ID: 29788429
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.
Alexander BM; Brown PD; Ahluwalia MS; Aoyama H; Baumert BG; Chang SM; Gaspar LE; Kalkanis SN; Macdonald DR; Mehta MP; Soffietti R; Suh JH; van den Bent MJ; Vogelbaum MA; Wefel JS; Lee EQ; Wen PY;
Lancet Oncol; 2018 Jan; 19(1):e33-e42. PubMed ID: 29304360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
